Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

26.1%

% of IDNA's 51 holdings also in CANC

24.5%

% of CANC's 49 holdings also in IDNA

Overlap by Weight
Sector Drift (IDNA minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IDNA
Weight
in CANC
Overlap
REVOLUTION MEDICINES, INC. 4.4% 6.3% 4.4%
ASTRAZENECA PLC 5.3% 4.3% 4.3%
EXELIXIS INC 5.3% 3.9% 3.9%
ARCELLX, INC. 3.6% 2.7% 2.7%
MERCK & CO. INC. 3.9% 2.6% 2.6%

Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CANC
BEIGENE, LTD. 5.9%
GSK PLC 5.6%
SANOFI-AVENTIS 5.6%
ROCHE HOLDING LTD 5.5%
SPRINGWORKS THERAPEUTICS, INC. 5.3%
TAKEDA PHARMACEUTICAL CO LTD 5.2%
GENMAB A/S 4.7%
BIONTECH SE SPONSORED ADR 4.0%
INCYTE CORP 3.3%
BIOCRYST PHARMACEUTICALS INC 3.3%
IDNA Underweight Relative to CANC
ROCHE HOLDINGS LTD-SPONS ADR -5.1%
ELI LILLY & CO -4.8%
NOVARTIS AG -4.3%
BRIDGEBIO PHARMA, INC. -4.3%
NUVALENT, INC. CLASS A -3.9%
SUMMIT THERAPEUTICS INC -3.9%
BRISTOL-MYERS SQUIBB CO -3.8%
GENMAB A/S SPONSORED ADR -3.5%
ZAI LAB LTD. UNSPONSORED ADR -3.1%
MERUS N.V. -3.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY